View Larger Image Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36% AbbVie shares are down 9.7% in the past month. Read More By David Hilbern|2022-05-02T05:14:58-05:00May 2, 2022|Bankruptcy|Comments Off on Wells Fargo says AbbVie is undervalued, sees biopharma stock rallying 36% Share This Story, Choose Your Platform! FacebookTwitterLinkedInEmail About the Author: David Hilbern Related Posts Market veteran is still bullish on tech despite earnings upset, and reveals his other top picks February 6, 2023 ‘The worst is over’: Tech investors are bullish on investing in China again February 6, 2023 Getting a Car After Bankruptcy February 6, 2023